- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | STENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK | 1 | Cision News | ||
| Mi | Communiqué from extraordinary general meeting in STENOCARE | 2 | Cision News | ||
| Di | Stenocare A/S: STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil | 46 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
Stenocare has received approval from the Danish Medicines Agency to start selling a new medical cannabis oil product to Danish... ► Artikel lesen | |
| STENOCARE Aktie jetzt für 0€ handeln | |||||
| 10.12. | STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com | 2 | Cision News | ||
| 03.12. | Danish Medical Marijuana Producer Stenocare To Launch Patented 10mg THC And 10mg CBD Oil In Norway | 1 | Benzinga.com | ||
| 02.12. | STENOCARE - Innovative New ASTRUM Product Officially Approved for Sale in Norway | 2 | Cision News | ||
| 28.11. | STENOCARE Celebrates Denmark's Permanent Legalisation of Medical Cannabis | 1 | Cision News | ||
| 26.11. | STENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production | 1 | Cision News | ||
| 26.11. | Notice to Extraordinary General Meeting in STENOCARE A/S | 2 | Cision News | ||
| 19.11. | STENOCARE Welcomes Danish Health Minister's Decision to Permanently Legalise Medical Cannabis for Patients | 1 | Cision News | ||
| 05.11. | Stenocare A/S: Interim Report Third Quarter 2024 | 123 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 30.09.2024. The report, which has not been reviewed... ► Artikel lesen | |
| 01.11. | STENOCARE Change in the Board of Directors | 1 | Cision News | ||
| 14.10. | Stenocare A/S: STENOCARE updates guidance for 2024 | 87 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen | |
| 21.08. | STENOCARE: Interim Report Second Quarter 2024 | 2 | Cision News | ||
| 08.08. | Danish Cannabis Company Stenocare To Launch 'Innovative' Medical Marijuana Oil In Germany | 1 | Benzinga.com | ||
| 31.07. | New innovative Stenocare Astrum 10-10 oil product is ready for sale in Germany | 1 | Cision News | ||
| 03.07. | First North Denmark: Stenocare A/S - increase in number of shares | 351 | GlobeNewswire | New shares in Stenocare A/S will be admitted to trading on Nasdaq First North
Growth Market Denmark as per 4 July 2024 due to exercise of warrants (TO 2) and
directed issue.
Name: ... ► Artikel lesen | |
| 28.06. | STENOCARE A/S: Directed issue, refinancing of debt from a major shareholder and new dates | 2 | Cision News | ||
| 25.06. | STENOCARE: TO2 Warrant Exercise subscribed to 88.3% | 1 | Cision News | ||
| 28.12.23 | First North Denmark: Stenocare A/S - increase in number of shares | 385 | GlobeNewswire | New shares in Stenocare A/S will be admitted to trading on Nasdaq First North
Growth Market Denmark as per 29 December 2023 due to a directed issue of shares
and exercise of warrants (TO 1).
Name:... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,100 | +0,49 % | Better Marijuana Stock: Aurora Cannabis or Tilray Brands? | ||
| ABBVIE | 169,00 | +0,33 % | AbbVie: Schon wieder - nächste Übernahme | Der Pharma-Riese AbbVie stärkt sein Immunologie-Portfolio. Für einen dreistelligen Millionen-Dollar-Betrag sichern sich die Amerikaner die Dienste des Biotech-Unternehmens Nimble Therapeutics. Das Übernahmeziel... ► Artikel lesen | |
| CANOPY GROWTH | 2,715 | +0,56 % | Ausverkauf und dann Comeback?: Darum sind Tilray, Canopy & Co. potenzielle Highflyer in 2025. Und darum nicht | © Foto: adobe.stock.comDas Jahresende bringt für den Cannabis-Sektor noch einmal Turbulenzen mit sich. Das Jahr endet, wie es verlief; könnte man salopp formulieren. Zudem dürfte Tilray, Canopy & Co.... ► Artikel lesen | |
| TILRAY BRANDS | 1,219 | +2,05 % | Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy? | ||
| INNOCAN PHARMA | 0,121 | 0,00 % | Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units | HERZLIYA, Israel and CALGARY, AB, Dec. 19, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,100 | -16,67 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| DERMAPHARM | 38,000 | 0,00 % | Leichter Wertverlust bei der Dermapharm-Aktie (37,05 €) | Im Minus liegt zur Stunde die Aktie von Dermapharm . Der jüngste Kurs betrug 37,05 Euro. Heute hat sich am deutschen Aktienmarkt die Dermapharm-Aktie zwischenzeitlich um 1,20 Prozent verbilligt. Der... ► Artikel lesen | |
| CRONOS GROUP | 1,880 | +0,27 % | Why Cronos Group (CRON) Is Among the Best Cannabis Stocks To Invest In? | ||
| SYNBIOTIC | 4,000 | -1,23 % | The new group continues to take shape; chg. est.: While SYNBIOTICs larges holding WEECO performs notably ... | Topic: While SYNBIOTICs largest holding WEECO performs notably ahead of expectations and the group added two new companies to its portfolio, it also decided to terminate the ongoing integration of CannaCare... ► Artikel lesen | |
| TRANSCANNA | 0,017 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| ORGANIGRAM | 1,460 | -2,14 % | Organigram Reports Fourth Quarter and Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer ("LP") of cannabis, announced its results for the fourth... ► Artikel lesen | |
| CRESCO LABS | 0,850 | -0,23 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,500 | -0,86 % | Multi-Bagger entdeckt!: Der europäische Cannabissektor wird in den nächsten Jahren auf 24 Mrd. $ explodieren - diese Aktie profitiert! | ||
| SNDL | 1,721 | -0,52 % | Why SNDL Inc. (SNDL) Is Among the Best Cannabis Stocks To Invest In? |
STENOCARE A/S gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,010 (-5,54 %) liegt der Kurs bei 0,171 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STENOCARE A/S finden Sie auf Wallstreet Online.
